Headwaters Capital Management's Q2 2024 investor letter noted a 1.3% return amid a calm market period. The fund focuses on companies with competitive advantages and strong growth potential. Notable stock pick highlighted was TransMedics Group, Inc.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing